FindMyKOL
Clinical trialNCT03144245CompletedPhase 1Interventional

Study of AMV564 in Patients With AML

SponsorAmphivena Therapeutics, Inc.Enrollment53Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a first in human, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of AMV564.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Francisco

    San Francisco, California, United States

  • Northwestern

    Chicago, Illinois, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • New York Medical College

    Hawthorne, New York, United States

  • Weill Cornell Medical College, the New York Presbyterian Hospital

    New York, New York, United States

  • the Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Md Anderson Cancer Center, the University of Texas

    Houston, Texas, United States

  • Fred Hutchinson Cancer Research

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AMV564
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Mar 2017
Primary completion
21 Jul 2020
Completion
5 Nov 2020
Last update posted
12 Oct 2021
Registered enrollment
53
Registry id
NCT03144245
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.